Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer

Krishnan K Mahadevan, Ana S Maldonado, Bingrui Li, Aaron A Bickert, Adrian Kacperczyk-Perdyan, Shreyasee V Kumbhar, Sujan Piya, Amari M Sockwell, Sami J Morse, Kent Arian, Hikaru Sugimoto, Shabnam Shalapour, David S Hong, Timothy P Heffernan, Anirban Maitra, Raghu Kalluri · 2026

Read Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer by Krishnan K Mahadevan, Ana S Maldonado, Bingrui Li, Aaron A Bickert, Adrian Kacperczyk-Perdyan, Shreyasee V Kumbhar, Sujan Piya, Amari M Sockwell, Sami J Morse, Kent Arian, Hikaru Sugimoto, Shabnam Shalapour, David S Hong, Timothy P Heffernan, Anirban Maitra, Raghu Kalluri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13518988.txt.

Description

Krishnan K Mahadevan and a large team find in 2026 that pancreatic cancer drugs targeting mutant Kras open a specific window for one immunotherapy partner. Kras inhibitors alone recruit T cells into tumors, but responses fade. Testing combinations in mouse pancreatic tumors, only anti-CTLA4 blockade, not five other immune agents, synergized strongly.

Kras targeting flooded the tumor with mixed T cells: effectors, exhausted cells, and regulatory cells. Anti-CTLA4 then reprogrammed the regulatory cells toward a naive state by dialing down AP-1 factors at the IL-35 gene, revived exhausted killers, and drew in organized lymphoid structures. Two Kras drugs, MRTX1133 and daraxonrasib, showed the effect. The team calls the pairing immediately relevant for trials.

Catalog record

CREATORKrishnan K Mahadevan, Ana S Maldonado, Bingrui Li, Aaron A Bickert, Adrian Kacperczyk-Perdyan, Shreyasee V Kumbhar, Sujan Piya, Amari M Sockwell, Sami J Morse, Kent Arian, Hikaru Sugimoto, Shabnam Shalapour, David S Hong, Timothy P Heffernan, Anirban Maitra, Raghu Kalluri
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13518988

Browse the full library · About the Tower of Babel